Filing Details
- Accession Number:
- 0001354488-15-004726
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-26 19:50:14
- Reporting Period:
- 2013-09-30
- Filing Date:
- 2015-10-26
- Accepted Time:
- 2015-10-26 19:50:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1378624 | Cellular Biomedicine Group Inc. | CBMG | Biological Products, (No Disgnostic Substances) (2836) | 861032927 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1569980 | (William) Wei Cao | 19925 Stevens Creek Blvd., Suite 100 Cupertino CA 95014 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-10-20 | 5,013 | $5.40 | 227,531 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-10-20 | 5,013 | $18.89 | 222,518 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2015-10-21 | 14,987 | $5.40 | 237,505 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-10-21 | 14,987 | $19.83 | 222,518 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non- Qualified Stock Option | Acquisiton | 2013-09-30 | 90,000 | $0.00 | 90,000 | $5.40 |
Common Stock | Non- Qualified Stock Option | Acquisiton | 2015-10-20 | 5,013 | $0.00 | 5,013 | $5.40 |
Common Stock | Non- Qualified Stock Option | Acquisiton | 2015-10-21 | 14,987 | $0.00 | 14,987 | $5.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
90,000 | 2023-09-29 | No | 4 | A | Direct | |
84,987 | 2023-09-29 | No | 4 | M | Direct | |
70,000 | 2023-09-29 | No | 4 | M | Direct |
Footnotes
- The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
- This option vests over a period of three-year years according to the following schedule: 1/36th per month following the vesting commencement date of 09/30/2013.